Diabetes induced changes in rat mesenchymal stem cells

Alexandra Stolzing, Donna Sellers, Owen Llewelyn, Andy Scutt

Research output: Contribution to journalArticleResearchpeer-review

84 Citations (Scopus)

Abstract

Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, is also associated with bone loss and impaired fracture healing. Mesenchymal stem cells (MSCs) have the potential to differentiate into osteoblasts, chondrocytes and adipocytes and other mesenchymal cells and play a central role in bone formation and repair. Because of this, we have investigated the possibility that diabetes has direct effects on MSCs in vivo and that this might represent a cellular basis for diabetes-induced osteoporosis. We isolated MSCs from rats with streptozotocin-induced diabetes and analysed them ex vivo for their ability to proliferate and differentiate in the fibroblastic colony-forming unit assay. Effects of diabetes on bone metabolism in vivo were determined by analysing tibiae from control and diabetic animals by quantitative computerized tomography. The total number of colonies and osteoblastic colonies staining positive for alkaline phosphatase were quantified and both colony size and number were found to be significantly reduced in diabetic rats. The changes appear to be mediated by the induction of apoptosis and senescence by advanced glycation end products (AGEs), together with an increase in the receptor for AGEs (RAGE). These changes were paralleled by extensive loss of trabecular bone in the tibiae of the diabetic animals. These data suggest that MSCs become exhausted during diabetes and lose their differentiation potential, leading to a net loss of trabecular bone. Therefore, direct effects on MSCs may be responsible for some of the orthopaedic effects associated with diabetes.

Original languageEnglish
Pages (from-to)453-65
Number of pages13
JournalCells Tissues Organs
Volume191
Issue number6
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Tibia
Colony-Forming Units Assay
Bone and Bones
Advanced Glycosylation End Products
Fracture Healing
Experimental Diabetes Mellitus
Chondrocytes
Osteoblasts
Vascular Diseases
Adipocytes
Osteogenesis
Osteoporosis
Orthopedics
Alkaline Phosphatase
Diabetes Mellitus
Tomography
Apoptosis
Staining and Labeling
Cancellous Bone

Cite this

Stolzing, Alexandra ; Sellers, Donna ; Llewelyn, Owen ; Scutt, Andy. / Diabetes induced changes in rat mesenchymal stem cells. In: Cells Tissues Organs. 2010 ; Vol. 191, No. 6. pp. 453-65.
@article{0ad514237c6f46679e84c0a0ae82de94,
title = "Diabetes induced changes in rat mesenchymal stem cells",
abstract = "Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, is also associated with bone loss and impaired fracture healing. Mesenchymal stem cells (MSCs) have the potential to differentiate into osteoblasts, chondrocytes and adipocytes and other mesenchymal cells and play a central role in bone formation and repair. Because of this, we have investigated the possibility that diabetes has direct effects on MSCs in vivo and that this might represent a cellular basis for diabetes-induced osteoporosis. We isolated MSCs from rats with streptozotocin-induced diabetes and analysed them ex vivo for their ability to proliferate and differentiate in the fibroblastic colony-forming unit assay. Effects of diabetes on bone metabolism in vivo were determined by analysing tibiae from control and diabetic animals by quantitative computerized tomography. The total number of colonies and osteoblastic colonies staining positive for alkaline phosphatase were quantified and both colony size and number were found to be significantly reduced in diabetic rats. The changes appear to be mediated by the induction of apoptosis and senescence by advanced glycation end products (AGEs), together with an increase in the receptor for AGEs (RAGE). These changes were paralleled by extensive loss of trabecular bone in the tibiae of the diabetic animals. These data suggest that MSCs become exhausted during diabetes and lose their differentiation potential, leading to a net loss of trabecular bone. Therefore, direct effects on MSCs may be responsible for some of the orthopaedic effects associated with diabetes.",
author = "Alexandra Stolzing and Donna Sellers and Owen Llewelyn and Andy Scutt",
note = "Copyright 2010 S. Karger AG, Basel.",
year = "2010",
doi = "10.1159/000281826",
language = "English",
volume = "191",
pages = "453--65",
journal = "Cells Tissues Organs",
issn = "1422-6405",
publisher = "S Karger AG",
number = "6",

}

Diabetes induced changes in rat mesenchymal stem cells. / Stolzing, Alexandra; Sellers, Donna; Llewelyn, Owen; Scutt, Andy.

In: Cells Tissues Organs, Vol. 191, No. 6, 2010, p. 453-65.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Diabetes induced changes in rat mesenchymal stem cells

AU - Stolzing, Alexandra

AU - Sellers, Donna

AU - Llewelyn, Owen

AU - Scutt, Andy

N1 - Copyright 2010 S. Karger AG, Basel.

PY - 2010

Y1 - 2010

N2 - Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, is also associated with bone loss and impaired fracture healing. Mesenchymal stem cells (MSCs) have the potential to differentiate into osteoblasts, chondrocytes and adipocytes and other mesenchymal cells and play a central role in bone formation and repair. Because of this, we have investigated the possibility that diabetes has direct effects on MSCs in vivo and that this might represent a cellular basis for diabetes-induced osteoporosis. We isolated MSCs from rats with streptozotocin-induced diabetes and analysed them ex vivo for their ability to proliferate and differentiate in the fibroblastic colony-forming unit assay. Effects of diabetes on bone metabolism in vivo were determined by analysing tibiae from control and diabetic animals by quantitative computerized tomography. The total number of colonies and osteoblastic colonies staining positive for alkaline phosphatase were quantified and both colony size and number were found to be significantly reduced in diabetic rats. The changes appear to be mediated by the induction of apoptosis and senescence by advanced glycation end products (AGEs), together with an increase in the receptor for AGEs (RAGE). These changes were paralleled by extensive loss of trabecular bone in the tibiae of the diabetic animals. These data suggest that MSCs become exhausted during diabetes and lose their differentiation potential, leading to a net loss of trabecular bone. Therefore, direct effects on MSCs may be responsible for some of the orthopaedic effects associated with diabetes.

AB - Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, is also associated with bone loss and impaired fracture healing. Mesenchymal stem cells (MSCs) have the potential to differentiate into osteoblasts, chondrocytes and adipocytes and other mesenchymal cells and play a central role in bone formation and repair. Because of this, we have investigated the possibility that diabetes has direct effects on MSCs in vivo and that this might represent a cellular basis for diabetes-induced osteoporosis. We isolated MSCs from rats with streptozotocin-induced diabetes and analysed them ex vivo for their ability to proliferate and differentiate in the fibroblastic colony-forming unit assay. Effects of diabetes on bone metabolism in vivo were determined by analysing tibiae from control and diabetic animals by quantitative computerized tomography. The total number of colonies and osteoblastic colonies staining positive for alkaline phosphatase were quantified and both colony size and number were found to be significantly reduced in diabetic rats. The changes appear to be mediated by the induction of apoptosis and senescence by advanced glycation end products (AGEs), together with an increase in the receptor for AGEs (RAGE). These changes were paralleled by extensive loss of trabecular bone in the tibiae of the diabetic animals. These data suggest that MSCs become exhausted during diabetes and lose their differentiation potential, leading to a net loss of trabecular bone. Therefore, direct effects on MSCs may be responsible for some of the orthopaedic effects associated with diabetes.

U2 - 10.1159/000281826

DO - 10.1159/000281826

M3 - Article

VL - 191

SP - 453

EP - 465

JO - Cells Tissues Organs

JF - Cells Tissues Organs

SN - 1422-6405

IS - 6

ER -